(Q35739814)

10 August 2017

1 reference

title

Inflammatory and oxidative markers in atherosclerosis: relationship to outcome (English)

1 reference

10 August 2017

0 references

1 reference

Mehdi H Shishehbor

1

1 reference

10 August 2017

Stanley L Hazen

series ordinal

2

1 reference

10 August 2017

publication date

1 May 2004

1 reference

Current Atherosclerosis Reports

10 August 2017

published in

1 reference

10 August 2017

volume

6

1 reference

10 August 2017

issue

3

1 reference

10 August 2017

page(s)

243-250

1 reference

Interferon-gamma and lipopolysaccharide potentiate monocyte tissue factor induction by C-reactive protein: relationship with age, sex, and hormone replacement treatment

10 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS11883-004-0038-1

CD40 ligation induces tissue factor expression in human vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-004-0038-1

Macrophage myeloperoxidase regulation by granulocyte macrophage colony-stimulating factor in human atherosclerosis and implications in acute coronary syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-004-0038-1

Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS11883-004-0038-1

C-reactive protein increases plasminogen activator inhibitor-1 expression and activity in human aortic endothelial cells: implications for the metabolic syndrome and atherothrombosis.

21 January 2018

1 reference

12 December 2020

Production of C-reactive protein and risk of coronary events in stable and unstable angina. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group

1 reference

12 December 2020

Increase in circulating products of lipid peroxidation (F2-isoprostanes) in smokers. Smoking as a cause of oxidative damage

1 reference

12 December 2020

Antioxidant vitamins and coronary heart disease

1 reference

12 December 2020

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients

1 reference

12 December 2020

T-cell-mediated lysis of endothelial cells in acute coronary syndromes

1 reference

12 December 2020

Is high-sensitivity C-reactive protein an effective screening test for cardiovascular risk?

1 reference

12 December 2020

Statins promote potent systemic antioxidant effects through specific inflammatory pathways

1 reference

12 December 2020

Myeloperoxidase, a leukocyte-derived vascular NO oxidase

1 reference

12 December 2020

Regulation of complement activation by C-reactive protein

1 reference

12 December 2020

Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study

1 reference

12 December 2020

C-reactive protein binds to both oxidized LDL and apoptotic cells through recognition of a common ligand: Phosphorylcholine of oxidized phospholipids

1 reference

12 December 2020

Myeloperoxidase-generated oxidants and atherosclerosis

1 reference

12 December 2020

Elevated serum C-reactive protein levels and early arterial changes in healthy children

1 reference

12 December 2020

Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction

1 reference

12 December 2020

Clinical application of C-reactive protein for cardiovascular disease detection and prevention

1 reference

12 December 2020

Nitric oxide modulates the catalytic activity of myeloperoxidase

1 reference

12 December 2020

C-reactive protein: a physiological activator of interleukin 6 receptor shedding.

1 reference

12 December 2020

Clinical use of C-reactive protein for the prognostic stratification of patients with ischemic heart disease

1 reference

12 December 2020

Soluble CD40 Ligand in Acute Coronary Syndromes

1 reference

12 December 2020

Measurement of F(2)-isoprostanes as an index of oxidative stress in vivo

1 reference

12 December 2020

Enhanced levels of soluble and membrane-bound CD40 ligand in patients with unstable angina. Possible reflection of T lymphocyte and platelet involvement in the pathogenesis of acute coronary syndromes

1 reference

12 December 2020

A functional variant of the myeloperoxidase gene is associated with cardiovascular disease in end-stage renal disease patients.

1 reference

12 December 2020

Association of nitrotyrosine levels with cardiovascular disease and modulation by statin therapy

1 reference

12 December 2020

Elevation of tumor necrosis factor-alpha and increased risk of recurrent coronary events after myocardial infarction

1 reference

12 December 2020

A self-fulfilling prophecy: C-reactive protein attenuates nitric oxide production and inhibits angiogenesis

1 reference

12 December 2020

Soluble CD40L: risk prediction after acute coronary syndromes

1 reference

12 December 2020

Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies

1 reference

12 December 2020

CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells

1 reference

12 December 2020

Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association

1 reference

12 December 2020

Products of the isoprostane pathway: unique bioactive compounds and markers of lipid peroxidation

1 reference

12 December 2020

Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress

1 reference

12 December 2020

Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses

1 reference

12 December 2020

Amino acid and protein oxidation in cardiovascular disease

1 reference

12 December 2020

Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis

1 reference

12 December 2020

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

1 reference

12 December 2020

Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease

1 reference

12 December 2020

Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species

1 reference

12 December 2020

Association between myeloperoxidase levels and risk of coronary artery disease

1 reference

12 December 2020

Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions

1 reference

12 December 2020

C-Reactive protein binds to apoptotic cells, protects the cells from assembly of the terminal complement components, and sustains an antiinflammatory innate immune response: implications for systemic autoimmunity

1 reference

12 December 2020

CD40 signaling and plaque instability

1 reference

12 December 2020

Prevention of In vitro neutrophil adhesion to endothelial cells through shedding of L-selectin by C-reactive protein and peptides derived from C-reactive protein

1 reference

12 December 2020

What is C-reactive protein telling us about coronary artery disease?

1 reference

12 December 2020

Pregnancy-associated plasma protein A as a marker of acute coronary syndromes

1 reference

12 December 2020

Direct proinflammatory effect of C-reactive protein on human endothelial cells

1 reference

12 December 2020

Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima

1 reference

12 December 2020

Soluble CD40L and cardiovascular risk in women

1 reference

12 December 2020

Using C-reactive protein to assess cardiovascular disease risk

1 reference

12 December 2020

Nitric oxide is a physiological substrate for mammalian peroxidases

1 reference

12 December 2020

Multimarker approach to risk stratification in non-ST elevation acute coronary syndromes: simultaneous assessment of troponin I, C-reactive protein, and B-type natriuretic peptide.

1 reference

12 December 2020

Local generation of C-reactive protein in diseased coronary artery venous bypass grafts and normal vascular tissue

1 reference

12 December 2020

Emerging role of myeloperoxidase and oxidant stress markers in cardiovascular risk assessment

1 reference

12 December 2020

Localization of distinct F2-isoprostanes in human atherosclerotic lesions

1 reference

12 December 2020

Increased thrombosis after arterial injury in human C-reactive protein-transgenic mice

1 reference

12 December 2020

C-reactive protein induces human peripheral blood monocytes to synthesize tissue factor

1 reference

12 December 2020

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

1 reference

12 December 2020

A functional myeloperoxidase polymorphic variant is associated with coronary artery disease in French-Canadians

1 reference

12 December 2020

N-terminal pro-brain natriuretic peptide and other risk markers for the separate prediction of mortality and subsequent myocardial infarction in patients with unstable coronary artery disease: a Global Utilization of Strategies To Open occluded arte

1 reference

12 December 2020

C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women

1 reference

12 December 2020

Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro

1 reference

12 December 2020

C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle

1 reference

12 December 2020

Induction of inflammatory cytokine release from cultured human monocytes by C-reactive protein

1 reference

12 December 2020

Use of antioxidant vitamins for the prevention of cardiovascular disease: meta-analysis of randomised trials

1 reference

12 December 2020

Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes

1 reference

12 December 2020

Should statin therapy be considered for patients with elevated C-reactive protein? The need for a definitive clinical trial

1 reference

12 December 2020

Is the oxidative modification hypothesis relevant to human atherosclerosis? Do the antioxidant trials conducted to date refute the hypothesis?

1 reference

12 December 2020

SEROLOGICAL REACTIONS IN PNEUMONIA WITH A NON-PROTEIN SOMATIC FRACTION OF PNEUMOCOCCUS

1 reference

12 December 2020

Stabilization of atherosclerotic plaques: new mechanisms and clinical targets

1 reference

12 December 2020

Prognostic value of myeloperoxidase in patients with chest pain

1 reference

12 December 2020

Interaction of C-reactive protein with artificial phosphatidylcholine bilayers

1 reference

12 December 2020

C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis

1 reference

12 December 2020

10.1007/S11883-004-0038-1

Identifiers

DOI

1 reference

10 August 2017

1 reference